Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04331717Phase 2Withdrawn
Phase 2, open-label, single-arm trial in obesity, sponsored by Sidney Kimmel Comprehensive Cancer Center. Primary endpoint: Number of participants who experience at least 5 percent weight loss at 6 months. Planned start Nov 2020; status: withdrawn.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04331717.